New Approach to Budget Impact Analysis - Ibrutinib In Treatment of Relapsed/Refractory Cll Patients in The Czech Republic
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2132
https://www.valueinhealthjournal.com/article/S1098-3015(16)33498-2/fulltext
Title :
New Approach to Budget Impact Analysis - Ibrutinib In Treatment of Relapsed/Refractory Cll Patients in The Czech Republic
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33498-2&doi=10.1016/j.jval.2016.09.2132
First page :
A719
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2020